Literature DB >> 24426166

Prokaryotic Expression, Identification and Bioinformatics Analysis of the Mycobacterium tuberculosis Rv3807c Gene Encoding the Putative Enzyme Committed to Decaprenylphosphoryl-d-arabinose Synthesis.

Lina Cai1, Xiaojiao Zhao2, Tao Jiang1, Juanjuan Qiu1, Lawrence Owusu1, Yufang Ma3, Bo Wang4, Yi Xin1.   

Abstract

Decaprenylphosphoryl-d-arabinofuranosyl (DPA), the immediate donor for the polymerized d-Araf residues of mycobacterial arabinan, is synthesized from 5-phosphoribose-1-diphosphate (PRPP) in three-step reactions. (i) PRPP is transferred to decaprenyl-phosphate (DP) to form decaprenylphosphoryl-d-5-phosphoribose (DPPR). (ii) DPPR is dephosphorylated to form decaprenylphosphoryl-d-ribose (DPR). (iii) DPR is formed to DPA by the epimerase. Mycobacterium tuberculosis Rv3806c and heteromeric Rv3790/Rv3791 have been identified as the PRPP: decaprenyl-phosphate 5-phosphoribosyltransferase and the epimerase respectively. Rv3807c, however, as the candidate of phospholipid phosphatase, catalyzing the biosynthesis of decapreny-l-phosphoryl-ribose (DPR) from decaprenylphosphoryl-β-d-5-phosphoribose by dephosphorylating, has no direct experimental evidence of its essentiality in any species of mycobacterium. In this study, Rv3807c gene was amplified from the genome of M. tuberculosis H37Rv by PCR, and was successfully expressed in Escherichia coli BL21 (DE3) via the recombinant plasmid pColdII-Rv3807c. The resulting protein with the 6× His-tag was identified by SDS-PAGE and Western blotting. The protein was predicted through bioinformatics to contain three transmembrane domains, the N-terminal peptide, and a core structure with phosphatidic acid phosphatase type2/haloperoxidase. This study provides biochemical and bioinformatics evidence for the importance of Rv3807c in mycobacteria, and further functional studies will be conducted for validating Rv3807c as a promising phospholipid phosphatase in the synthetic pathway of DPA.

Entities:  

Keywords:  Decaprenylphosphoryl-d-arabinose (DPA); Mycobacterium tuberculosis; Rv3807c

Year:  2013        PMID: 24426166      PMCID: PMC3889854          DOI: 10.1007/s12088-013-0418-8

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  17 in total

1.  Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl residues of mycobacterial arabinan, is formed via a two-step epimerization of decaprenylphosphoryl ribose.

Authors:  Katarína Mikusová; Hairong Huang; Tetsuya Yagi; Marcelle Holsters; Danny Vereecke; Wim D'Haeze; Michael S Scherman; Patrick J Brennan; Michael R McNeil; Dean C Crick
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

2.  The effect of MSMEG_6402 gene disruption on the cell wall structure of Mycobacterium smegmatis.

Authors:  Tao Jiang; Lianqi He; Yaoyao Zhan; Shizhu Zang; Yufang Ma; Xiaojiao Zhao; Cuili Zhang; Yi Xin
Journal:  Microb Pathog       Date:  2011-05-06       Impact factor: 3.738

Review 3.  Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis.

Authors:  D C Crick; S Mahapatra; P J Brennan
Journal:  Glycobiology       Date:  2001-09       Impact factor: 4.313

4.  Polyprenyl phosphate biosynthesis in Mycobacterium tuberculosis and Mycobacterium smegmatis.

Authors:  D C Crick; M C Schulbach; E E Zink; M Macchia; S Barontini; G S Besra; P J Brennan
Journal:  J Bacteriol       Date:  2000-10       Impact factor: 3.490

Review 5.  Antituberculars which target decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1: state of art.

Authors:  Silvia Buroni; Maria Rosalia Pasca; Ana Luisa de Jesus Lopes Ribeiro; Giulia Degiacomi; Elisabetta Molteni; Giovanna Riccardi
Journal:  Appl Microbiol Biotechnol       Date:  2012-04-18       Impact factor: 4.813

6.  Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria.

Authors:  B A Wolucka; M R McNeil; E de Hoffmann; T Chojnacki; P J Brennan
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

7.  Characterization of the Mycobacterium tuberculosis 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase: potential for drug development.

Authors:  Hyungjin Eoh; Amanda C Brown; Lori Buetow; William N Hunter; Tanya Parish; Devinder Kaur; Patrick J Brennan; Dean C Crick
Journal:  J Bacteriol       Date:  2007-10-05       Impact factor: 3.490

8.  Biosynthetic origin of mycobacterial cell wall arabinosyl residues.

Authors:  M Scherman; A Weston; K Duncan; A Whittington; R Upton; L Deng; R Comber; J D Friedrich; M McNeil
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

Review 9.  Biosynthesis of D-arabinose in mycobacteria - a novel bacterial pathway with implications for antimycobacterial therapy.

Authors:  Beata A Wolucka
Journal:  FEBS J       Date:  2008-04-15       Impact factor: 5.542

Review 10.  Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis.

Authors:  P J Brennan
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

View more
  3 in total

1.  The biosynthetic origin of ribofuranose in bacterial polysaccharides.

Authors:  Steven D Kelly; Danielle M Williams; Jeremy T Nothof; Taeok Kim; Todd L Lowary; Matthew S Kimber; Chris Whitfield
Journal:  Nat Chem Biol       Date:  2022-04-07       Impact factor: 16.174

2.  Two-Year Follow-up Study of Mycobacterium tuberculosis Antigen-Driven IFN-γ Responses and Macrophage sCD14 Levels After Tuberculosis Contact.

Authors:  Magdalena Druszczynska; Marcin Wlodarczyk; Grzegorz Kielnierowski; Malwina Kawka; Wieslawa Rudnicka
Journal:  Indian J Microbiol       Date:  2016-02-23       Impact factor: 2.461

3.  Updated and standardized genome-scale reconstruction of Mycobacterium tuberculosis H37Rv, iEK1011, simulates flux states indicative of physiological conditions.

Authors:  Erol S Kavvas; Yara Seif; James T Yurkovich; Charles Norsigian; Saugat Poudel; William W Greenwald; Sankha Ghatak; Bernhard O Palsson; Jonathan M Monk
Journal:  BMC Syst Biol       Date:  2018-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.